Quality of life after endoscopic procedures for chronic pancreatitis : A multicentre study
Parhiala, Mikael; Nøjgaard, Camilla; Bartholdy, Andreas; Waage, Anne; Ignatavičius, Povilas; Engjom, Trond; Dimcevski, Georg; Nordaas, Ingrid Kvåle; Kalaitzakis, Evangelos; Drewes, Asbjørn M.; Hadi, Amer; Olesen, Søren S.; Poulsen, Jakob L.; Laukkarinen, Johanna (2023)
Parhiala, Mikael
Nøjgaard, Camilla
Bartholdy, Andreas
Waage, Anne
Ignatavičius, Povilas
Engjom, Trond
Dimcevski, Georg
Nordaas, Ingrid Kvåle
Kalaitzakis, Evangelos
Drewes, Asbjørn M.
Hadi, Amer
Olesen, Søren S.
Poulsen, Jakob L.
Laukkarinen, Johanna
2023
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-2023112010077
https://urn.fi/URN:NBN:fi:tuni-2023112010077
Kuvaus
Peer reviewed
Tiivistelmä
Background: Chronic Pancreatitis (CP) causes morphological changes in the pancreatic tissue, leading to complications and pain, which may require endoscopic interventions. Objective: Our aim was to determine the frequency of endoscopic procedures (EP) in CP patients and to analyse pain and quality of life (QoL) in these patients after their EP. Methods: This study included 1327 CP patients from the Scandinavian Baltic Pancreatic Club (SBPC) database including four countries and eight centres. We analysed patients undergoing EPs and gathered information on the EP, pancreatic function, pain, disease and duration. The EORTC C-30 QoL questionnaire was gathered prospectively and multivariable analysis was conducted on independent parameters between the groups. The reference population had no interventions (n = 870). Results: 260 CP patients (22%) underwent EPs, median one year (range 0–39 years) after CP diagnosis. 68% were males. The median age was 59 (20–90) years. Most common aetiological factors were alcohol in 65% and smoking in 71%. Extracorporeal shock wave lithotripsy (ESWL) was used in 6% of the CP population and in 21% of the EP group. Biliary duct stenting was performed on 37% and pancreatic stenting was performed on 56% of the patients. There was no difference in pain patterns between patients who had pancreatic stenting and the reference population. The EP group had slightly better QoL (p = 0.047), functioning and fewer symptoms than the reference population, in the multivariable analysis there was no interaction effect analysis between the groups. The pancreatic stent group had better QoL and the same amount of pain than the reference group. The patients who needed later surgery (23%) had more pain (p = 0.043) and fatigue (p = 0.021). Conclusions: One in five of the CP patients underwent EP. These patients scored higher on QoL responses and had better symptom scores. CP patients who had pancreatic stenting performed had the same pain patterns as the reference population. Randomised prospective trials are needed to determine the effect of endoscopy procedures on CP patients.
Kokoelmat
- TUNICRIS-julkaisut [19236]